NSF Peer Review

In his response to the petition we recently submitted requesting reforms in the National Science Foundation’s peer review process (“NSF Official Scoffs At Allegations, Asking: ‘What Secret Filing System?’ The Scientist, Sept. 18, 1989, page 13), Jim McCullough [director of NSF’s program evaluation staff] accuses us of various distortions and errors. However, he does not rebut any of the basic arguments we made, nor even the most fundamental point of our petition&#

Written byEric Glitzenstein
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In his response to the petition we recently submitted requesting reforms in the National Science Foundation’s peer review process (“NSF Official Scoffs At Allegations, Asking: ‘What Secret Filing System?’ The Scientist, Sept. 18, 1989, page 13), Jim McCullough [director of NSF’s program evaluation staff] accuses us of various distortions and errors. However, he does not rebut any of the basic arguments we made, nor even the most fundamental point of our petition—that NSF’s peer review system has not satisfactorily safeguarded the legal rights of grant applicants. Indeed, the fact that McCullough neglects to even mention, let alone address, the federal statutes on which our petition is principally based—the Privacy Act and Federal Advisory Committee Act—simply serves to strengthen our contention that the agency has not taken the steps necessary to fully comply with these laws.

The most glaring example of McCullough’s failure to come to grips with the substance of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies